Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Other Non-Current Assets (2016 - 2025)

Kiora Pharmaceuticals' Other Non-Current Assets history spans 11 years, with the latest figure at $59687.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 1371.21% year-over-year to $59687.0; the TTM value through Dec 2025 reached $59687.0, up 1371.21%, while the annual FY2025 figure was $59687.0, 1371.21% up from the prior year.
  • Other Non-Current Assets reached $59687.0 in Q4 2025 per KPRX's latest filing, up from $58135.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $61007.0 in Q2 2025 to a low of $4057.0 in Q4 2024.
  • Average Other Non-Current Assets over 5 years is $34172.2, with a median of $39414.0 recorded in 2024.
  • Peak YoY movement for Other Non-Current Assets: plummeted 92.22% in 2023, then skyrocketed 1371.21% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $45000.0 in 2021, then decreased by 26.62% to $33023.0 in 2022, then tumbled by 87.08% to $4267.0 in 2023, then decreased by 4.92% to $4057.0 in 2024, then surged by 1371.21% to $59687.0 in 2025.
  • Per Business Quant, the three most recent readings for KPRX's Other Non-Current Assets are $59687.0 (Q4 2025), $58135.0 (Q3 2025), and $61007.0 (Q2 2025).